This Article Full Text Full Text (PDF) All Versions of this Article: 34/7/1723    most recent 01.STR.0000078372.76670.83v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hähnel, S. Articles by Sartor, K. Search for Related Content PubMed PubMed Citation Articles by Hähnel, S. Articles by Sartor, K. Pubmed/NCBI databases Substance via MeSH Related Collections Embolic stroke Emergency treatment of Stroke Thrombolysis Angioplasty and Stenting Coagulation and fibronolysis

(Stroke. 2003;34:1723.)
© 2003 American Heart Association, Inc.

Original Contributions

Local Intra-arterial Fibrinolysis of Thromboemboli Occurring During Neuroendovascular Procedures With Recombinant Tissue Plasminogen Activator

Stefan Hähnel, MD; Peter D. Schellinger, MD; Alexander Gutschalk, MD; Karsten Geletneky, MD; Marius Hartmann, MD; Michael Knauth, MD Klaus Sartor, MD

From the Divisions of Neuroradiology (S.H., M.H., M.K., K.S.) and Neurology (P.D.S., A.G.), Department of Neurology, and Department of Neurosurgery (K.G.), University of Heidelberg Medical Center, Heidelberg, Germany.

Correspondence to Stefan Hähnel, MD, Division of Neuroradiology, Department of Neurology, University of Heidelberg Medical Center, Im Neuenheimer Feld 400, D 69120 Heidelberg, Germany. E-mail Stefan_Haehnel{at}med uni-heidelberg. de

Background and Purpose— There is a lack of systematic data regarding local intra-arterial fibrinolysis (LIF) of thromboemboli occurring during neuroendovascular procedures with the use of recombinant tissue plasminogen activator (rtPA). We report our technique for treating LIF of intracerebral thromboemboli occurring during neuroendovascular procedures.

Methods— Nine of 723 patients (1.2%) who underwent neuroendovascular procedures during the period from January 1997 to September 2002 suffered thromboembolic complications. These patients were treated by LIF with a maximum dose of 0.9 mg rtPA per kilogram body weight. Recanalization was categorized as successful (Thrombolysis in Myocardial Infarction [TIMI] grade 2 or 3) versus unsuccessful (TIMI grade 0 or 1), and clinical outcome was categorized as independent (Rankin Scale score 0 to 2) versus dependent or dead (Rankin Scale score 3 to 6).

Results— The minimum time between thrombus detection and beginning of LIF was 10 minutes, and the maximum time was 90 minutes. Successful recanalization was achieved in 4 of 9 patients (44%). All 9 patients suffered cerebral ischemic infarctions, and none of the patients sustained intracerebral hemorrhage. Two patients (22%) died from malignant brain infarctions. Four patients (44%) remained moderately disabled, and 3 patients (33%) were severely disabled 3 months after LIF.

Conclusions— Although we used relatively high doses of rtPA, the recanalization rates and clinical outcome of LIF in our patients were not satisfactory. Strategies for the prevention of thromboemboli during neuroendovascular procedures must be improved, and novel fibrinolytic or thrombolytic techniques should be developed.

Key Words: embolism, intracranial • fibrinolysis • thrombosis • tissue plasminogen activator

This article has been cited by other articles:

				M. Arnold, U. Fischer, G. Schroth, K. Nedeltchev, J. Isenegger, L. Remonda, S. Windecker, C. Brekenfeld, and H. P. Mattle Intra-arterial Thrombolysis of Acute Iatrogenic Intracranial Arterial Occlusion Attributable to Neuroendovascular Procedures or Coronary Angiography Stroke, May 1, 2008; 39(5): 1491 - 1495. [Abstract] [Full Text] [PDF]

				M. K. Varma, K. Price, V. Jayakrishnan, B. Manickam, and G. Kessell Anaesthetic considerations for interventional neuroradiology Br. J. Anaesth., July 1, 2007; 99(1): 75 - 85. [Abstract] [Full Text] [PDF]

				T. Ries, J.-H. Buhk, T. Kucinski, E. Goebell, U. Grzyska, H. Zeumer, and J. Fiehler Intravenous Administration of Acetylsalicylic Acid During Endovascular Treatment of Cerebral Aneurysms Reduces the Rate of Thromboembolic Events Stroke, July 1, 2006; 37(7): 1816 - 1821. [Abstract] [Full Text] [PDF]

				A. I. Qureshi Editorial Comment--Thromboembolic Events During Neuroendovascular Procedures Stroke, July 1, 2003; 34(7): 1728 - 1729. [Full Text] [PDF]